Therefore, the targeting of different sites of IL-18 by antibodies induced by vaccine A and D, plus the different roles of IL-18Rα and IL-18Rβ chain in inducing signaling pathways, might lead to the different effects of vaccine A and D in the amelioration of murine colitis. The gene discussed is IL18R1; the disease is colitis.